#clinical #investment
Drug, Pharmaceutical drug, Pharmacology, Clinical trial, Pre-clinical development, Pharmaceutical industry

RedX Pharma CEO focuses on pipeline that found Lilly’s rising star

On Jan 28, 2021
@Dominic_Tyer shared
RT @AlderleyPark: Great @pharmaphorum read ft. @RedxPharma's CEO 👉 "Thanks to the new #investment, plus partnerships with @AstraZeneca & @JazzPharma, the company is well positioned to develop two promising #clinical stage drugs in-house, at least until the end of phase 2." https://t.co/R4ByIzznXH
Open

Back in 2017, the UK biotech RedX Pharma had to sell off its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for $40 million.

pharmaphorum.com
On Jan 28, 2021
@Dominic_Tyer shared
RT @AlderleyPark: Great @pharmaphorum read ft. @RedxPharma's CEO 👉 "Thanks to the new #investment, plus partnerships with @AstraZeneca & @JazzPharma, the company is well positioned to develop two promising #clinical stage drugs in-house, at least until the end of phase 2." https://t.co/R4ByIzznXH
Open

RedX Pharma CEO focuses on pipeline that found Lilly’s rising star

RedX Pharma CEO focuses on pipeline that found Lilly’s rising star

Back in 2017, the UK biotech RedX Pharma had to sell off its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for ...

Redx shares soar after IPF drug licence deal with AstraZeneca

Redx shares soar after IPF drug licence deal with AstraZeneca

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic diseases drug to AstraZeneca.

Small Pharma Driving Big Pharma Innovation

Small Pharma Driving Big Pharma Innovation

The Path to R&D Innovation Lies in the Power of Small Pharma

Big pharma is using AI and machine learning in drug discovery and development to save lives

Big pharma is using AI and machine learning in drug discovery and development to save lives

Insider Intelligence details how AI and machine learning can help at every stage of the drug discovery process, from research to clinical trials.

AstraZeneca

AstraZeneca

[3] It has Research and development concentrated in three strategic centres; Cambridge, Gothenburg, Sweden and Gaithersburg, U.S.[4] AstraZeneca has a portfolio of products for major ...

Struggling Redx out-licenses fibrotic asset to AstraZeneca, sees stock sky rocket

Struggling Redx out-licenses fibrotic asset to AstraZeneca, sees stock sky rocket

AstraZeneca is picking up a delayed preclinical fibrosis candidate from RedX in a deal that gives the U.K. biotech a much needed cash boost which also saw its shares sky rocket.

Redx snags potential $377M deal with Astrazeneca for fibrosis-targeting RXC-006

Redx snags potential $377M deal with Astrazeneca for fibrosis-targeting RXC-006

LONDON – Redx Pharma plc is in the process of handing its RXC-006 program over to Astrazeneca plc, after signing a potential $377 million development and commercialization deal for the ...

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

The pharmaceutical business is perhaps the only industry on the planet, where to get the product from idea to market the company needs to spend about a decade, several billion dollars, and ...

Bayer hands over a big drug R&D operation to CRO amid an ongoing restructuring effort

Bayer hands over a big drug R&D operation to CRO amid an ongoing restructuring effort

Bayer’s 400-strong small molecule R&D team is being carved out and handed to a CRO, where they’ll continue to work for Bayer. The pharma player — which has been steadily finding ways to ...

Hunting for New Drugs with AI

Hunting for New Drugs with AI

The pharmaceutical industry is in a drug-discovery slump. How much can AI help?

The billion-dollar race to change how drugs are made

The billion-dollar race to change how drugs are made

Alphabet’s AI lab DeepMind is proving that artificial intelligence can be game-changing for drug discovery. Could savvy upstarts upend Big Pharma?

Innovation Supports Growth at Big Pharma/Big Biotech Companies

Innovation Supports Growth at Big Pharma/Big Biotech Companies

Moats and returns on invested capital look stable for companies with a solid list of pipeline drugs.

Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More

Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More

It’s October: a time of days growing shorter, leaves changing color, and phone calls in the wee hours that rouse scientists from slumber notifying them

Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19

Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19

Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on ...

Drug research turns to artificial intelligence in COVID-19 fight

Drug research turns to artificial intelligence in COVID-19 fight

Tech company locks down government funding to repurpose drugs for virus treatment

How the Pharma Industry Pulled Off the Pivot to COVID-19

How the Pharma Industry Pulled Off the Pivot to COVID-19

The urgent need for tests and therapeutics has brought companies together and pushed researchers to work at breakneck speeds.

Negative Perceptions Of Biopharma — Let's Get The Ugly On The Table

Negative Perceptions Of Biopharma — Let's Get The Ugly On The Table

A Life Science Leader reader shares their thoughts on why the biopharmaceutical industry’s reputation is so dismal, but also proposes solutions ...